<unk>  is a somatostatin analog that is FDA approved for the treatment of Cushing’s disease for whom pituitary surgery is not an option or has not been curative.   Common adverse reactions include diarrhea, nausea, hyperglycemia, cholelithiasis, headache, abdominal pain, fatigue, and diabetes mellitus.
Pasireotide
Ziconotide
Etelcalcetide
Crofelemer
Follitropin alfa
Romiplostim
Andexanet alfa
Tisagenlecleucel